Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Launches PKU GOLIKE(R) KRUNCH in Germany and Italy
APR Expands PKU GOLIKE(R) Product Line with More Convenient, Chewable Tablet Option GENEVA, SWITZERLAND /…
APR Expands PKU GOLIKE(R) Product Line with More Convenient, Chewable Tablet Option GENEVA, SWITZERLAND /…
Data Integration Partnership of Leading Geospatial Companies Further Strengthens EQ’s Proprietary LOCUS Platform TORONTO, ON…
JENNINGS, LA / ACCESSWIRE / September 9, 2021 / JD Bancshares, Inc. (OTCQX:JDVB), the bank…
NEWPORT BEACH, CA / ACCESSWIRE / September 9, 2021 / GBX International Group, Inc. (OTC…
CEO Sam Rubin Unveils Mission for Leadership in Global Photonics Value Chain ORLANDO, FL /…
LYON, France, Sept. 10, 2021 (GLOBE NEWSWIRE) — Adocia (Euronext Paris: FR0011184241 – ADOC), a…
An interim analysis will be conducted 28 days following enrollment of 245 patients (40% of…
SEATTLE, Sept. 09, 2021 (GLOBE NEWSWIRE) — Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical…
VANCOUVER, British Columbia, Sept. 09, 2021 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the…
LEXINGTON, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
SAN CARLOS, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. (Nasdaq: BCDA), today announced it…
BERLIN and SAN DIEGO, Sept. 09, 2021 (GLOBE NEWSWIRE) — atai Life Sciences (Nasdaq: ATAI) (“atai”), a clinical-stage…
BETHESDA, Md., Sept. 09, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or…
WALTHAM, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or…
WESTLAKE VILLAGE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage…
REDWOOD CITY, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading…
OAKS met the primary endpoint for both monthly and every-other-month treatment with pegcetacoplan, demonstrating a…
EMERYVILLE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage…
Tracking to Announce Top line data in Q1 2022 REDWOOD CITY, Calif., Sept. 09, 2021…
SAN DIEGO, Sept. 09, 2021 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology…